HCC: RNA-Sequencing in Cirrhosis
Hepatocellular carcinoma (HCC) ranks the most common types of cancer worldwide. As the fourth leading cause of cancer-related deaths, its prognosis remains poor. Most patients developed HCC on the basis of chronic liver disease. Cirrhosis is an important precancerous lesion for HCC. However, the mol...
Main Authors: | Haoyu Wang, Wenjie Shi, Jing Lu, Yuan Liu, Wei Zhou, Zekun Yu, Shengying Qin, Junwei Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/1/141 |
Similar Items
-
Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
by: Yingying Jiang, et al.
Published: (2020-09-01) -
A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
by: Xiang-Xu Wang, et al.
Published: (2022-09-01) -
Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma
by: Junyu Huo, et al.
Published: (2023-01-01) -
Single-Cell RNA-Seq Analysis Reveals Microenvironmental Infiltration of Plasma Cells and Hepatocytic Prognostic Markers in HCC With Cirrhosis
by: Siwen Zhang, et al.
Published: (2020-11-01) -
A novel signature based on microvascular invasion predicts the recurrence of HCC
by: Binbin Du, et al.
Published: (2020-07-01)